WeightWatchers (WW)

Personal wellness company WeightWatchers (NASDAQ:WW) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 11.7% year on year to $162.8 million. On the other hand, the company’s full-year revenue guidance of $627.5 million at the midpoint came in 0.7% below analysts’ estimates. Its GAAP loss of $0.58 per share was 71.4% above analysts’ consensus estimates.

Company Overview

Known by many for its old cable television commercials, WeightWatchers (NASDAQ:WW) is a wellness company offering a range of products and services promoting weight loss and healthy habits.

The Consumer Discretionary sector, by definition, is made up of companies selling non-essential goods and services. When economic conditions deteriorate or tastes shift, consumers can easily cut back or eliminate these purchases. For long-term investors with five-year holding periods, this creates a structural challenge: the sector is inherently hit-driven, with low switching costs and fickle customers. As a result, only a handful of companies can reliably grow demand and compound earnings over long periods, which is why our bar is high and High Quality ratings are rare.

Some consumer discretionary companies don’t fall neatly into a category because their products or services are unique. Although their offerings may be niche, these companies have often found more efficient or technology-enabled ways of doing or selling something that has existed for a while. Technology can be a double-edged sword, though, as it may lower the barriers to entry for new competitors and allow them to do serve customers better.

WeightWatchers's fitness and wellness peers include BODi (NYSE:BODY), MyFitnessPal, Noom, Cult.fit, and Trainerize.

Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, WeightWatchers’s demand was weak and its revenue declined by 12.4% per year. This was below our standards and is a sign of poor business quality.

Long-term growth is the most important, but within consumer discretionary, product cycles are short and revenue can be hit-driven due to rapidly changing trends and consumer preferences. WeightWatchers’s annualized revenue declines of 10.6% over the last two years suggest its demand continued shrinking.

This quarter, WeightWatchers’s revenue fell by 11.7% year on year to $162.8 million but beat Wall Street’s estimates by 8.7%.

Looking ahead, sell-side analysts expect revenue to decline by 10.8% over the next 12 months, similar to its two-year rate. This projection is underwhelming and implies its newer products and services will not accelerate its top-line performance yet.

Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals.

WeightWatchers’s operating margin has shrunk over the last 12 months and averaged 10.4% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

In Q4, WeightWatchers generated an operating margin profit margin of negative 7.9%, down 16.6 percentage points year on year. This contraction shows it was less efficient because its expenses increased relative to its revenue.

Although earnings are undoubtedly valuable for assessing company performance, we believe cash is king because you can’t use accounting profits to pay the bills.

While WeightWatchers’s free cash flow broke even this quarter, the broader story hasn’t been so clean. Over the last two years, WeightWatchers’s demanding reinvestments to stay relevant have drained its resources, putting it in a pinch and limiting its ability to return capital to investors. Its free cash flow margin averaged negative 3.4%, meaning it lit $3.37 of cash on fire for every $100 in revenue.

WeightWatchers broke even from a free cash flow perspective in Q4. The company’s cash profitability regressed as it was 1.7 percentage points lower than in the same quarter last year, but it’s still above its two-year average. We wouldn’t read too much into this quarter’s decline because investment needs can be seasonal, causing short-term swings. Long-term trends trump temporary fluctuations.

Looking forward, analysts predict WeightWatchers will generate cash on a full-year basis. Their consensus estimates imply its free cash flow margin of negative 4% for the last 12 months will increase to positive 9.1%, giving it more money to invest.

WeightWatchers reported $166.6 million of cash and $468.6 million of debt on its balance sheet in the most recent quarter. As investors in high-quality companies, we primarily focus on two things: 1) that a company’s debt level isn’t too high and 2) that its interest payments are not excessively burdening the business.

With $139.9 million of EBITDA over the last 12 months, we view WeightWatchers’s 2.2× net-debt-to-EBITDA ratio as safe. We also see its $39.87 million of annual interest expenses as appropriate. The company’s profits give it plenty of breathing room, allowing it to continue investing in growth initiatives.

It was good to see WeightWatchers beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. On the other hand, its full-year EBITDA guidance missed and its full-year revenue guidance fell slightly short of Wall Street’s estimates. Overall, this print was mixed. The stock traded up 2.7% to $21.67 immediately following the results.

Updated: March 16, 2026 at 11:04 PM EDT

Are you wondering whether to buy WeightWatchers or pass? We urge investors to not only consider the latest earnings results but also longer-term business quality and valuation as well.

WeightWatchers doesn’t pass our quality test. While its Forecasted free cash flow margin suggests the company will have more capital to invest or return to shareholders next year, the downside is its number of members has disappointed. On top of that, its projected EPS for the next year is lacking.

WeightWatchers’s EV-to-EBITDA ratio based on the next 12 months is 4.8x. While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are better stocks to buy right now.

Wall Street analysts have a consensus one-year price target of $42.83 on the company (compared to the current share price of $21.26).

Although the price target is bullish, readers should exercise caution because analysts tend to be overly optimistic. The firms they work for, often big banks, have relationships with companies that extend into fundraising, M&A advisory, and other rewarding business lines. As a result, they typically hesitate to say bad things for fear they will lose out. We at StockStory do not suffer from such conflicts of interest, so we’ll always tell it like it is.